What is the proper administration protocol for lyophilized (freeze-dried) amphotericin B (antifungal medication)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Administration Protocol for Lyophilized Amphotericin B

Lyophilized amphotericin B should be reconstituted with sterile water for injection to create a 5 mg/mL concentrate, then further diluted with 5% dextrose solution to a final concentration of 0.1 mg/mL before administration via slow intravenous infusion over 2-6 hours. 1

Reconstitution Process

  • Rapidly add 10 mL of sterile water for injection (without bacteriostatic agents) directly into the vial containing the lyophilized cake using a sterile needle (minimum 20-gauge) and syringe 1
  • Shake the vial immediately until a clear colloidal solution forms (5 mg/mL concentration) 1
  • Further dilute this concentrate 1:50 with 5% dextrose injection to achieve the recommended final concentration of 0.1 mg/mL 1
  • Ensure the pH of the dextrose solution is above 4.2 to prevent precipitation; if below 4.2, add buffer solution 1
  • Use strict aseptic technique throughout preparation as the product contains no preservatives 1

Administration Guidelines

  • Administer via intravenous infusion over 2-6 hours depending on dose 1
  • Consider administering a test dose (1 mg in 20 mL of 5% dextrose solution over 20-30 minutes) before full therapeutic dosing 1
  • Monitor vital signs every 30 minutes for 2-4 hours during initial administration 1
  • Pre-medicate with diphenhydramine or acetaminophen to reduce infusion-related reactions 2
  • Administer 1 L of normal saline before and after infusion to reduce nephrotoxicity in patients who can tolerate fluids 2, 3

Dosing Recommendations

  • For conventional amphotericin B deoxycholate: 0.5-1.5 mg/kg/day IV 4, 5
  • For severe or life-threatening infections: 0.7-1.0 mg/kg/day 4, 5
  • For lipid formulations:
    • Liposomal amphotericin B: 3-5 mg/kg/day IV (standard infections) or 5-10 mg/kg/day IV (CNS involvement) 4, 3
    • Amphotericin B lipid complex: 5 mg/kg/day IV 4
    • Amphotericin B colloidal dispersion: 3-6 mg/kg/day IV 4

Special Administration Situations

  • For intravitreal injection: 5-10 μg/0.1 mL sterile water 2
  • For intraventricular administration through CNS devices: 0.01-0.5 mg in 2 mL 5% dextrose in water 2
  • For bladder irrigation: 50 mg/L sterile water daily for 5 days 2

Important Precautions

  • Do not reconstitute with saline solutions as this will cause precipitation 1
  • Do not use if there is any evidence of precipitation or foreign matter 1
  • If using an in-line filter, ensure the mean pore diameter is not less than 1.0 micron 1
  • Store reconstituted solution at 4-8°C if not used immediately 6
  • Discard unused solution as it contains no preservatives 1

Monitoring During Therapy

  • Monitor renal function, electrolytes, and liver function tests regularly 5
  • Watch for infusion-related reactions including fever, chills, nausea, and vomiting 5
  • For persistent fungal infections despite therapy, investigate for deep tissue focus of infection 5

Lipid formulations of amphotericin B have similar efficacy but significantly less nephrotoxicity compared to conventional formulations, making them preferable for patients with renal impairment or those requiring higher doses 4, 7.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Liposomal Amphotericin B Treatment for Severe Fungal Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Amphotericin B Dosage and Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Amphotericin B Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Practical guidelines for preparing and administering amphotericin B.

American journal of hospital pharmacy, 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.